Access Point of Care builds on Burnet Institute’s expertise in the development, field-testing and implementation of point-of-care (POC) tests.
With capabilities across the scope of the value chain, Access Point of Care can overcome the key barriers to implementation of novel POC technologies, with the aim to reduce the burden of diseases in the most hard-to-reach populations.
Access Point of Care’s mission is to increase access to lifesaving treatments for infectious diseases in hard-to-reach populations in resource-poor countries, by demonstrating the accuracy and feasibility of existing and novel point-of-care tests and enabling their implementation.
- To develop new diagnostic tests and innovative technologies for better management of diseases particularly at POC
- To coordinate field-testing and implementation studies for existing and newly-developed POC technologies, focused on optimising the acceptability, accessibility and availability in resource-poor countries
- To assist in overcoming market barriers by developing capacity for implementation of these technologies, through education and training at the health facility, laboratory and community level
- To collaborate with industry, local clinicians, research sectors, funders, aid agencies and governments to bring new and improved POC technologies to the communities that need them.
Current projects pipeline
Access Point of Care is looking to work with partners to ensure POC tests reach their intended market. We have a successful track record collaborating with industry, academia, development agencies and local governments to overcome the barriers to entry in these markets.
Partnerships could include:
- Development and laboratory evaluation of novel POC tests
- Field evaluation and implementation studies
- Building capacity at the primary health level through education and training.